Improving IPO market still not an exit path.Published in:Journal of Commercial Biotechnology, 2013, v. 19, n. 1, p. 53, doi. 10.5912/jcb593By:Burrill, G. StevenPublication type:Article
The NASH drug dash.Published in:Nature Reviews Drug Discovery, 2015, v. 14, n. 7, p. 447, doi. 10.1038/nrd4667By:Chi, Kelly RaePublication type:Article
Intercept price quadruples in a day.Published in:Nature Biotechnology, 2014, v. 32, n. 3, p. 207, doi. 10.1038/nbt0314-207By:Orelli, BrianPublication type:Article